PCM
EW icon

Pinz Capital Management’s Edwards Lifesciences EW Stock Holding History

Pinz Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-960
Closed -$60K – 140
2020
Q1 		$60K Buy
+960
New +$69.2K 0.16% 53

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Pinz Capital Management's EW Position: Q2 2020 in Review

Pinz Capital Management sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 960 shares — an estimated $60K sold.

Pinz Capital Management first reported a position in EW in Q1 2020 and held it in 1 quarter. The position peaked at $60K in Q1 2020. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • Pinz Capital Management reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • Pinz Capital Management sold 960 Edwards Lifesciences shares in Q2 2020, an estimated $60K.
  • Pinz Capital Management first reported a position in Edwards Lifesciences in Q1 2020 and held it in 1 quarter.
  • Pinz Capital Management's Edwards Lifesciences position peaked at $60K in Q1 2020.
  • 1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Pinz Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.